Researchers have discovered a new enzymatic function of the Epstein-Barr Virus (EBV) protein EBNA1, a critical factor in EBV's ability to transform human cells and cause cancer. Study provides new indications for inhibiting EBNA1 function, opening up fresh avenues for development of therapies to treat EBV-associated cancers.
from Latest Science News -- ScienceDaily https://ift.tt/394NoSR
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment